India’s pharmaceutical exports are approaching $30 billion, propelled by a robust CRDMO ecosystem and expanding GCCs. The sector’s shift from generics to innovation-driven growth, backed by regulatory ease and R&D investment, positions India as a future global leader in pharma by 2047.
